| Expression pattern: |
UP |
| Associated gene: |
FKBP1A |
| Associated microRNA: |
miR-515-5p |
| Biological function: |
Circ-PAPPA promotes PCa cell viability, proliferation, migration, invasion, glycolysis and in vivo tumour growth, and inhibits apoptosis. |
| Molecular mechanism: |
Circ-PAPPA acts as a ceRNA by sequestering miR-515-5p, thereby inducing FKBP1A expression. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; MTT; EdU Staining; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model |
| Clinical significance: |
Up-regulation of circ-PAPPA in PCa patients was associated with increased Gleason score, positive lymph node metastasis and advanced clinical T stage. |
| Description: |
Circ-PAPPA (hsa_circ_0088233) is up-regulated in prostate cancer tissues and cell lines. It promotes malignant phenotypes including proliferation, migration, invasion, glycolysis and xenograft tumour growth while suppressing apoptosis, mainly through sponging miR-515-5p to increase FKBP1A expression. Higher circ-PAPPA expression is associated with aggressive clinicopathological features such as higher Gleason score, lymph node metastasis and advanced clinical T stage. |
| Confidence score: |
0.8006 |